Form 8-K - Current report:
SEC Accession No. 0001493152-25-011680
Filing Date
2025-08-07
Accepted
2025-08-07 08:30:08
Documents
14
Period of Report
2025-08-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 43519
2 EX-10.1 ex10-1.htm EX-10.1 210017
3 EX-99.1 ex99-1.htm EX-99.1 12955
  Complete submission text file 0001493152-25-011680.txt   484848

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pcsa-20250804.xsd EX-101.SCH 3059
5 XBRL LABEL FILE pcsa-20250804_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE pcsa-20250804_pre.xml EX-101.PRE 22388
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 251191786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)